Stock listing
NASDAQ:VTVT vTv Therapeutics Inc. Stock
Home listing (NASDAQ) of vTv Therapeutics Inc.
Follow vTv Therapeutics Inc. into a list and get an email when it puts out news.
Share price · NASDAQ:VTVT
$24.15 USD -1.02 (-4.1%)
Close on Nov 2, 2026
- Day range
- $23.72 – $24.72 USDNov 2, 2026
- Volume
- 20,787 sharesNov 2, 2026
- Market cap
- $95.49M USDAt the close on Nov 2, 2026 · price × 3.95M shares outstanding
- 52-week range
- $20.23 – $44.00 USDLowest and highest trades, Nov 3, 2025 – Nov 2, 2026
- Traded on an average day
- $1.50M USDMedian day 30,900 shares · last 3 months, Aug 3, 2026 – Nov 2, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:VTVT · Home | $24.15 USD | -1.02 (-4.1%) | 20,787 | $24.72 | $24.72 | $23.72 | $25.17 | Close on Nov 2, 2026 |
| Frankfurt:5VT0 | €22.80 EUR | -0.20 (-0.9%) | — | €22.80 | €22.80 | €22.80 | €23.00 | Close on Oct 30, 2026 |
Daily closes
Last 3 months, Aug 3, 2026 – Nov 2, 2026 · NASDAQ:VTVT · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $24.15 | -1.02 | -4.1% | $24.72 | $24.72 | $23.72 | 20,787 | |
| $25.17 | -1.21 | -4.6% | $25.85 | $26.31 | $24.69 | 14,217 | |
| $26.38 | +0.66 | +2.6% | $26.17 | $27.00 | $25.76 | 41,638 | |
| $25.72 | 0.00 | 0.0% | $25.55 | $25.96 | $25.00 | 17,881 | |
| $25.72 | -0.09 | -0.3% | $26.06 | $26.44 | $25.47 | 11,112 | |
| $25.81 | +0.26 | +1.0% | $25.74 | $26.56 | $25.70 | 14,607 | |
| $25.55 | -1.61 | -5.9% | $27.31 | $27.31 | $25.35 | 21,500 | |
| $27.16 | -0.61 | -2.2% | $27.79 | $28.05 | $27.02 | 10,800 | |
| $27.77 | -0.075 | -0.3% | $28.06 | $29.24 | $27.55 | 14,100 | |
| $27.85 | +0.905 | +3.4% | $27.47 | $28.56 | $27.07 | 21,200 | |
| $26.94 | +0.40 | +1.5% | $26.70 | $27.23 | $26.61 | 17,900 | |
| $26.54 | -1.05 | -3.8% | $27.49 | $27.49 | $25.95 | 11,800 | |
| $27.59 | +0.07 | +0.3% | $27.80 | $28.87 | $27.42 | 22,200 | |
| $27.52 | -0.71 | -2.5% | $27.91 | $28.86 | $27.49 | 20,100 | |
| $28.23 | -2.23 | -7.3% | $30.75 | $31.22 | $27.87 | 41,800 | |
| $30.46 | -0.72 | -2.3% | $31.12 | $31.18 | $30.29 | 17,100 | |
| $31.18 | +1.10 | +3.7% | $30.16 | $31.18 | $30.10 | 12,800 | |
| $30.08 | -0.93 | -3.0% | $31.03 | $31.22 | $29.80 | 44,300 | |
| $31.01 | +0.98 | +3.3% | $29.95 | $31.50 | $29.86 | 26,100 | |
| $30.03 | -0.30 | -1.0% | $30.50 | $30.50 | $29.55 | 27,900 | |
| $30.33 | -0.24 | -0.8% | $31.56 | $31.56 | $30.29 | 14,900 | |
| $30.57 | -1.28 | -4.0% | $32.20 | $32.32 | $30.57 | 18,000 | |
| $31.85 | +1.01 | +3.3% | $30.99 | $32.28 | $30.99 | 34,300 | |
| $30.84 | +0.84 | +2.8% | $30.11 | $31.14 | $29.98 | 30,900 | |
| $30.00 | -0.52 | -1.7% | $30.34 | $30.69 | $30.00 | 85,100 | |
| $30.52 | +0.31 | +1.0% | $29.75 | $31.45 | $29.68 | 111,900 | |
| $30.21 | -0.52 | -1.7% | $30.60 | $30.91 | $29.79 | 28,800 | |
| $30.73 | +0.15 | +0.5% | $30.57 | $31.57 | $30.24 | 18,000 | |
| $30.58 | -0.52 | -1.7% | $31.03 | $31.40 | $30.47 | 18,900 | |
| $31.10 | -0.20 | -0.6% | $31.32 | $32.38 | $31.07 | 11,200 | |
| $31.30 | -0.50 | -1.6% | $31.45 | $32.00 | $31.02 | 22,700 | |
| $31.80 | +0.40 | +1.3% | $31.15 | $32.09 | $31.05 | 74,400 | |
| $31.40 | +0.94 | +3.1% | $30.89 | $32.11 | $30.77 | 33,400 | |
| $30.46 | 0.00 | 0.0% | $30.37 | $30.86 | $29.98 | 91,500 | |
| $30.46 | -0.98 | -3.1% | $31.30 | $31.90 | $29.76 | 45,300 | |
| $31.44 | -0.53 | -1.7% | $31.80 | $32.53 | $31.44 | 22,200 | |
| $31.97 | +0.11 | +0.3% | $32.24 | $32.54 | $31.29 | 13,700 | |
| $31.86 | -1.43 | -4.3% | $33.00 | $33.00 | $31.85 | 46,300 | |
| $33.29 | +0.50 | +1.5% | $32.99 | $34.14 | $32.78 | 39,500 | |
| $32.79 | -0.56 | -1.7% | $33.35 | $33.38 | $32.48 | 28,100 | |
| $33.35 | -0.12 | -0.4% | $32.97 | $33.73 | $32.97 | 12,100 | |
| $33.47 | +0.07 | +0.2% | $33.96 | $33.96 | $32.88 | 20,900 | |
| $33.40 | +1.45 | +4.5% | $32.55 | $34.00 | $32.15 | 39,800 | |
| $31.95 | -0.05 | -0.2% | $31.81 | $32.59 | $31.55 | 52,700 | |
| $32.00 | -0.36 | -1.1% | $32.25 | $32.25 | $31.35 | 94,200 | |
| $32.36 | -0.44 | -1.3% | $32.79 | $33.00 | $31.80 | 90,200 | |
| $32.80 | -0.77 | -2.3% | $33.07 | $34.09 | $32.57 | 58,400 | |
| $33.57 | -0.34 | -1.0% | $33.55 | $34.76 | $32.90 | 117,200 | |
| $33.91 | +0.02 | +0.1% | $33.80 | $34.55 | $33.45 | 59,300 | |
| $33.89 | +0.635 | +1.9% | $33.42 | $34.66 | $32.87 | 18,000 | |
| $33.26 | +0.175 | +0.5% | $33.19 | $33.85 | $32.78 | 26,700 | |
| $33.08 | +0.185 | +0.6% | $32.54 | $33.54 | $31.84 | 62,700 | |
| $32.90 | +1.415 | +4.5% | $31.91 | $33.20 | $31.91 | 22,600 | |
| $31.48 | +0.17 | +0.5% | $31.05 | $31.76 | $30.31 | 70,300 | |
| $31.31 | +1.19 | +4.0% | $29.93 | $31.42 | $29.49 | 38,800 | |
| $30.12 | -0.73 | -2.4% | $31.14 | $31.14 | $28.76 | 74,800 | |
| $30.85 | -0.93 | -2.9% | $32.04 | $32.04 | $30.36 | 35,400 | |
| $31.78 | -2.51 | -7.3% | $33.41 | $33.41 | $31.42 | 50,500 | |
| $34.29 | 0.00 | 0.0% | $34.29 | $34.29 | $34.29 | 170,800 | |
| $34.29 | -1.08 | -3.1% | $34.89 | $35.50 | $33.93 | 97,700 | |
| $35.37 | +0.76 | +2.2% | $34.61 | $36.51 | $34.39 | 147,500 | |
| $34.61 | +0.22 | +0.6% | $34.44 | $35.31 | $32.85 | 140,000 | |
| $34.39 | +2.33 | +7.3% | $32.06 | $34.77 | $31.88 | 102,700 | |
| $32.06 | -0.33 | -1.0% | $32.95 | $33.45 | $31.50 | 63,400 | |
| $32.39 | +0.04 | +0.1% | $32.15 | $32.77 | $31.63 | 171,200 |
- Ticker
- NASDAQ:VTVT
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Oct 27, 2026
vTv Therapeutics Announces First Participant Randomized in Phase 2a Pilot Study Evaluating Cadisegliatin in Individuals with Type 1 Diabetes (T1D) Using Hybrid Closed-Loop (HCL) Insulin Delivery Systems
Latest deck · Mar 10, 2026
Investor Presentation (March 2026)
Investor deck · 25 slides
Latest news
vTv Therapeutics Announces First Participant Randomized in Phase 2a Pilot Study Evaluating Cadisegliatin in Individuals with Type 1 Diabetes (T1D) Using Hybrid Closed-Loop (HCL) Insulin Delivery Systems
Oct 27, 2026
Closed $25.72 (-0.3%) on Oct 27, 2026
vTv Therapeutics Announces Oral Presentation at Breakthrough T1D Clinical and Research Congress 2026
Oct 10, 2026
Closed $30.46 (-2.3%) on Oct 12, 2026
vTv Therapeutics Announces FDA Orphan Drug Designation for HPPD in Sickle Cell Disease
Oct 7, 2026
Closed $30.08 (-3.0%) on Oct 8, 2026
vTv Therapeutics to Host Virtual KOL Event on Hypoglycemia in Type 1 Diabetes and the Cadisegliatin Phase 3 Program on October 20, 2026
Oct 6, 2026
Closed $30.03 (-1.0%) on Oct 6, 2026
vTv Therapeutics Announces Completion of Enrollment in Phase 3 CATT1 Study of Cadisegliatin in Type 1 Diabetes (T1D)
Oct 5, 2026
Closed $30.33 (-0.8%) on Oct 5, 2026
vTv Therapeutics to Participate in September Investor Conferences
Sep 2, 2026
Closed $33.40 (+4.5%) on Sep 2, 2026
VTv Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update
Aug 6, 2026
Closed $34.61 (+0.6%) on Aug 6, 2026
VTv Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(4)
Jun 3, 2026
Closed $32.94 (-0.2%) on Jun 3, 2026
VTv Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Jun 2, 2026
Closed $32.94 (-0.2%) on Jun 3, 2026
vTv Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update
May 13, 2026
Closed $38.43 (+21.4%) on May 14, 2026
Decks
Investor Presentation (March 2026)
Investor deck · 25 slides · Mar 10, 2026
Investor Presentation (February 2026)
Investor deck · 25 slides · Feb 26, 2026
Investor Presentation (May 2025)
Investor deck · 19 slides · May 16, 2025
Investor Presentation (March 2025)
Investor deck · 30 slides · Mar 31, 2025
vTv Therapeutics Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 18 in the last 12 months · 102 in all · newest Oct 27, 2026 · oldest 2019
- Decks
- 18 decks · latest Mar 10, 2026
Where vTv Therapeutics Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:VTVT · Home listing · This page | NASDAQ | United States | USD |
| BOATS:VTVT | BOATS | United States | USD |
| Frankfurt:5VT0 | Frankfurt | Germany | EUR |
| Lang & Schwarz:A3EWXG | Lang & Schwarz | Germany | EUR |
| Stuttgart:5VT0 | Stuttgart | Germany | EUR |
| Tradegate:5VT0 | Tradegate | Germany | EUR |
Log in to ask 6ix AI your own questions about vTv Therapeutics Inc.